Blood Purification Equipment Market (By Type: Dialysis, CRRT, Hemoperfusion, Others; By Product: Portable, Stationary; By Application: Acute Kidney Injury, Infectious Diseases, Sepsis, Renal Diseases, COVID-19, Others; By End User: Hospitals and Clinics, Dialysis Centers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Blood Purification Equipment Market 

5.1. COVID-19 Landscape: Blood Purification Equipment Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Blood Purification Equipment Market, By Type

8.1. Blood Purification Equipment Market, by Type, 2023-2032

8.1.1. Dialysis

8.1.1.1. Market Revenue and Forecast (2021-2032)

8.1.2. CRRT

8.1.2.1. Market Revenue and Forecast (2021-2032)

8.1.3. Hemoperfusion

8.1.3.1. Market Revenue and Forecast (2021-2032)

8.1.4. Others (plasma exchange, immunoadsorption, etc.)

8.1.4.1. Market Revenue and Forecast (2021-2032)

Chapter 9. Global Blood Purification Equipment Market, By Product

9.1. Blood Purification Equipment Market, by Product, 2023-2032

9.1.1. Portable

9.1.1.1. Market Revenue and Forecast (2021-2032)

9.1.2. Stationary

9.1.2.1. Market Revenue and Forecast (2021-2032)

Chapter 10. Global Blood Purification Equipment Market, By Application 

10.1. Blood Purification Equipment Market, by Application, 2023-2032

10.1.1. Acute Kidney Injury

10.1.1.1. Market Revenue and Forecast (2021-2032)

10.1.2. Infectious Diseases

10.1.2.1. Market Revenue and Forecast (2021-2032)

10.1.3. Sepsis

10.1.3.1. Market Revenue and Forecast (2021-2032)

10.1.4. Renal Diseases

10.1.4.1. Market Revenue and Forecast (2021-2032)

10.1.5. COVID-19

10.1.5.1. Market Revenue and Forecast (2021-2032)

10.1.6. Others

10.1.6.1. Market Revenue and Forecast (2021-2032)

Chapter 11. Global Blood Purification Equipment Market, By End User 

11.1. Blood Purification Equipment Market, by End User, 2023-2032

11.1.1. Hospitals and Clinics

11.1.1.1. Market Revenue and Forecast (2021-2032)

11.1.2. Dialysis Centers

11.1.2.1. Market Revenue and Forecast (2021-2032)

11.1.3. Others

11.1.3.1. Market Revenue and Forecast (2021-2032)

Chapter 12. Global Blood Purification Equipment Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Type (2021-2032)

12.1.2. Market Revenue and Forecast, by Product (2021-2032)

12.1.3. Market Revenue and Forecast, by Application (2021-2032)

12.1.4. Market Revenue and Forecast, by End User (2021-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Type (2021-2032)

12.1.5.2. Market Revenue and Forecast, by Product (2021-2032)

12.1.5.3. Market Revenue and Forecast, by Application (2021-2032)

12.1.5.4. Market Revenue and Forecast, by End User (2021-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Type (2021-2032)

12.1.6.2. Market Revenue and Forecast, by Product (2021-2032)

12.1.6.3. Market Revenue and Forecast, by Application (2021-2032)

12.1.6.4. Market Revenue and Forecast, by End User (2021-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Type (2021-2032)

12.2.2. Market Revenue and Forecast, by Product (2021-2032)

12.2.3. Market Revenue and Forecast, by Application (2021-2032)

12.2.4. Market Revenue and Forecast, by End User (2021-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Type (2021-2032)

12.2.5.2. Market Revenue and Forecast, by Product (2021-2032)

12.2.5.3. Market Revenue and Forecast, by Application (2021-2032)

12.2.5.4. Market Revenue and Forecast, by End User (2021-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Type (2021-2032)

12.2.6.2. Market Revenue and Forecast, by Product (2021-2032)

12.2.6.3. Market Revenue and Forecast, by Application (2021-2032)

12.2.6.4. Market Revenue and Forecast, by End User (2021-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Type (2021-2032)

12.2.7.2. Market Revenue and Forecast, by Product (2021-2032)

12.2.7.3. Market Revenue and Forecast, by Application (2021-2032)

12.2.7.4. Market Revenue and Forecast, by End User (2021-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Type (2021-2032)

12.2.8.2. Market Revenue and Forecast, by Product (2021-2032)

12.2.8.3. Market Revenue and Forecast, by Application (2021-2032)

12.2.8.4. Market Revenue and Forecast, by End User (2021-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Type (2021-2032)

12.3.2. Market Revenue and Forecast, by Product (2021-2032)

12.3.3. Market Revenue and Forecast, by Application (2021-2032)

12.3.4. Market Revenue and Forecast, by End User (2021-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Type (2021-2032)

12.3.5.2. Market Revenue and Forecast, by Product (2021-2032)

12.3.5.3. Market Revenue and Forecast, by Application (2021-2032)

12.3.5.4. Market Revenue and Forecast, by End User (2021-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Type (2021-2032)

12.3.6.2. Market Revenue and Forecast, by Product (2021-2032)

12.3.6.3. Market Revenue and Forecast, by Application (2021-2032)

12.3.6.4. Market Revenue and Forecast, by End User (2021-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Type (2021-2032)

12.3.7.2. Market Revenue and Forecast, by Product (2021-2032)

12.3.7.3. Market Revenue and Forecast, by Application (2021-2032)

12.3.7.4. Market Revenue and Forecast, by End User (2021-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Type (2021-2032)

12.3.8.2. Market Revenue and Forecast, by Product (2021-2032)

12.3.8.3. Market Revenue and Forecast, by Application (2021-2032)

12.3.8.4. Market Revenue and Forecast, by End User (2021-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Type (2021-2032)

12.4.2. Market Revenue and Forecast, by Product (2021-2032)

12.4.3. Market Revenue and Forecast, by Application (2021-2032)

12.4.4. Market Revenue and Forecast, by End User (2021-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Type (2021-2032)

12.4.5.2. Market Revenue and Forecast, by Product (2021-2032)

12.4.5.3. Market Revenue and Forecast, by Application (2021-2032)

12.4.5.4. Market Revenue and Forecast, by End User (2021-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Type (2021-2032)

12.4.6.2. Market Revenue and Forecast, by Product (2021-2032)

12.4.6.3. Market Revenue and Forecast, by Application (2021-2032)

12.4.6.4. Market Revenue and Forecast, by End User (2021-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Type (2021-2032)

12.4.7.2. Market Revenue and Forecast, by Product (2021-2032)

12.4.7.3. Market Revenue and Forecast, by Application (2021-2032)

12.4.7.4. Market Revenue and Forecast, by End User (2021-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Type (2021-2032)

12.4.8.2. Market Revenue and Forecast, by Product (2021-2032)

12.4.8.3. Market Revenue and Forecast, by Application (2021-2032)

12.4.8.4. Market Revenue and Forecast, by End User (2021-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Type (2021-2032)

12.5.2. Market Revenue and Forecast, by Product (2021-2032)

12.5.3. Market Revenue and Forecast, by Application (2021-2032)

12.5.4. Market Revenue and Forecast, by End User (2021-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Type (2021-2032)

12.5.5.2. Market Revenue and Forecast, by Product (2021-2032)

12.5.5.3. Market Revenue and Forecast, by Application (2021-2032)

12.5.5.4. Market Revenue and Forecast, by End User (2021-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Type (2021-2032)

12.5.6.2. Market Revenue and Forecast, by Product (2021-2032)

12.5.6.3. Market Revenue and Forecast, by Application (2021-2032)

12.5.6.4. Market Revenue and Forecast, by End User (2021-2032)

Chapter 13. Company Profiles

13.1. Cytosorbents Corporation

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Baxter International, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Cerus Corporation

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Jafron Biomedical Co., Ltd.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Spectra Medical, Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. B. Braun Melsungen AG

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. and Nikkiso Co, Ltd

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. ExThera Medical Corporation

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Aethlon Medical, Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Fresenius SE & Co. KGaA

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

PROCEED TO BUY :

   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample